APA (7th ed.) Citation

Westermann, I., Gastine, S., Müller, C., Rudolph, W., Peters, F., Bloos, F., . . . Hagel, S. (2021). Population pharmacokinetics and probability of target attainment in patients with sepsis under renal replacement therapy receiving continuous infusion of meropenem: Sustained low‐efficiency dialysis and continuous veno‐venous haemodialysis. British journal of clinical pharmacology, 87(11), 4293-4303. https://doi.org/10.1111/bcp.14846

Chicago Style (17th ed.) Citation

Westermann, Isabella, Silke Gastine, Carsten Müller, Wiebke Rudolph, Frank Peters, Frank Bloos, Mathias Pletz, and Stefan Hagel. "Population Pharmacokinetics and Probability of Target Attainment in Patients with Sepsis Under Renal Replacement Therapy Receiving Continuous Infusion of Meropenem: Sustained Low‐efficiency Dialysis and Continuous Veno‐venous Haemodialysis." British Journal of Clinical Pharmacology 87, no. 11 (2021): 4293-4303. https://doi.org/10.1111/bcp.14846.

MLA (9th ed.) Citation

Westermann, Isabella, et al. "Population Pharmacokinetics and Probability of Target Attainment in Patients with Sepsis Under Renal Replacement Therapy Receiving Continuous Infusion of Meropenem: Sustained Low‐efficiency Dialysis and Continuous Veno‐venous Haemodialysis." British Journal of Clinical Pharmacology, vol. 87, no. 11, 2021, pp. 4293-4303, https://doi.org/10.1111/bcp.14846.